Discovery of a potent CDKs/FLT3 PROTAC with enhanced differentiation and proliferation inhibition for AML.

MLA

Wu, Mingfei, et al. “Discovery of a Potent CDKs/FLT3 PROTAC with Enhanced Differentiation and Proliferation Inhibition for AML.” European Journal of Medicinal Chemistry, vol. 275, Sept. 2024, p. 116539. EBSCOhost, https://doi.org/10.1016/j.ejmech.2024.116539.

APA

Wu, M., Wang, W., Mao, X., Wu, Y., Jin, Y., Liu, T., Lu, Y., Dai, H., Zeng, S., Huang, W., Wang, Y., Yao, X., Che, J., Ying, M., & Dong, X. (2024). Discovery of a potent CDKs/FLT3 PROTAC with enhanced differentiation and proliferation inhibition for AML. European Journal of Medicinal Chemistry, 275, 116539. https://doi.org/10.1016/j.ejmech.2024.116539

Chicago

Wu, Mingfei, Wei Wang, Xinfei Mao, Yiquan Wu, Yuyuan Jin, Tao Liu, Yan Lu, et al. 2024. “Discovery of a Potent CDKs/FLT3 PROTAC with Enhanced Differentiation and Proliferation Inhibition for AML.” European Journal of Medicinal Chemistry 275 (September): 116539. doi:10.1016/j.ejmech.2024.116539.